EMM 310525
Alternative Names: EE/TX-525; Ethinylestradiol/TX-525Latest Information Update: 08 Feb 2018
At a glance
- Originator Theramex SAM
- Class Alkylated estrogenic steroids; Norpregnatrienes; Oral contraceptives; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pregnancy
Most Recent Events
- 01 Feb 2018 Teva Women's Health was sold by Teva Pharmaceuticals to CVC Capital Partners, to create an international pharmaceutical company dedicated to Women’s Health named Theramex
- 08 May 2007 Discontinued - Phase-II for Contraception/Pregnancy (Prevention) in Europe (PO)
- 15 Nov 2001 EMM 310525 is available for licensing in USA and Japan (http://www.theramex.mc)